Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.49 |
| ▸ | SCD | O00767 | 3/20 | 0.45 |
| ▸ | USP2 | O75604 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | HMGCR | P04035 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6134249 | 0.93 | TSHR (0.46) | SMN1; SMN2USP2KDM4EMEN1ALOX15 | |
| SCHEMBL6133208 | 0.93 | NAMPT (0.49) | SMN1; SMN2SCDUSP2KDM4EMEN1 | |
| SCHEMBL6134645 | 0.91 | ADORA2A (0.49) | SMN1; SMN2SCDUSP2KDM4EMEN1 | |
| SCHEMBL6133825 | 0.89 | ADORA2A (0.46) | SMN1; SMN2SCDUSP2KDM4EMEN1 | |
| SCHEMBL6133196 | 0.86 | L3MBTL1 (0.40) | SMN1; SMN2KDM4EHSD17B10L3MBTL1CYP3A4 | |
| SCHEMBL6134702 | 0.86 | ADORA2A (0.49) | SMN1; SMN2USP2KDM4EMEN1ALOX15 | |
| SCHEMBL6133260 | 0.86 | P2RX3 (0.43) | SCDHMGCR | |
| SCHEMBL6133519 | 0.85 | CYP3A4 (0.43) | SMN1; SMN2KDM4EMEN1KMT2AL3MBTL1 | |
| SCHEMBL6929083 | 0.85 | SMN1; SMN2 (0.50) | SMN1; SMN2SCDKDM4EALDH1A1TSHR | |
| SCHEMBL6133569 | 0.84 | HDAC6 (0.45) | SMN1; SMN2KDM4EMEN1KMT2AHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050004134-A1 | Thiazole derivative and pharmaceutical use thereof | ASTELLAS PHARMA INC. (JP) | 2005-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050004134-A1 | Thiazole derivative and pharmaceutical use thereof | MC2R, CYP2C9, OXTR | SMN1; SMN2 3135/4885SCD 2942/4885USP2 4097/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.